Showing results (181-190 of 194) with videos related to
Sort By:
Pageof 20
Diabetologia|July 1, 1993
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitusL Groop, A Ekstrand, C Forsblom, et al.Journal of Clinical Pathology|April 18, 2000
Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type)C P Maury, M Liljeström, G Boysen, et al.Scandinavian Journal of Clinical and Laboratory Investigation|May 6, 2003
Studies of cytokine levels in bronchoalveolar fluid lavage from patients with interstitial lung diseasesH Wolff, A M Teppo, P Mutanen, et al.Nature Genetics|October 1, 1992
Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187A de la Chapelle, R Tolvanen, G Boysen, et al.Diabetologia|March 1, 1995
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDMC M Forsblom, J G Eriksson, A V Ekstrand, et al.Experimental Eye Research|June 1, 2001
Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRKI S Tuominen, T M Tervo, A M Teppo, et al.Journal of Veterinary Internal Medicine|April 6, 2006
Magnetic resonance imaging findings in Finnish Spitz dogs with focal epilepsyR Viitmaa, S Cizinauskas, L A Bergamasco, et al.American Journal of Human Genetics|July 1, 1992
Exclusion of the gelsolin gene on 9q32-34 as the cause of familial lattice corneal dystrophy type IA Wiens, S Marles, J Safneck, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysmJ Juvonen, H M Surcel, J Satta, et al.Diabetologia|January 29, 2000
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetesP Ebeling, A M Teppo, H A Koistinen, et al.Pageof 20